Imatinib mesylate (gleevec) in the treatment of 2 patients with philadelphia-positive ALL relapsing after allogeneic stem cell transplantation

Saved in:
Bibliographic Details
Published inInternational journal of hematology Vol. 75; no. 4; pp. 440 - 442
Main Authors SUGIMOTO, Keiji, MIKOSHIBA, Michiaki, OHASHI, Kazuteru, AKIYAMA, Hideki, SAKAMAKI, Hisashi
Format Journal Article
LanguageEnglish
Published Tokyo Springer 01.05.2002
Springer Nature B.V
Subjects
Adult
Antineoplastic agents
Benzamides
Biological and medical sciences
Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
Female
Humans
Imatinib Mesylate
Male
Medical sciences
Pharmacology. Drug treatments
Piperazines - administration & dosage
Piperazines - standards
Precursor Cell Lymphoblastic Leukemia-Lymphoma - drug therapy
Precursor Cell Lymphoblastic Leukemia-Lymphoma - therapy
Pyrimidines - administration & dosage
Pyrimidines - standards
Salvage Therapy
Stem Cell Transplantation
Transplantation, Homologous
Treatment Outcome
Chromosomal aberration
Human
Relapse
Enzyme
Transferases
Acute
Stem cell
Adjuvant treatment
Hematopoietic cell
Homograft
Malignant hemopathy
Philadelphia chromosome
Case study
Chemotherapy
Treatment
Lymphoproliferative syndrome
Abnormal chromosome
Graft
Evolution
Inhibitor
Acute lymphocytic leukemia
Protein-tyrosine kinase
Online AccessGet full text

Cover

More Information
ISSN:0925-5710
1865-3774
DOI:10.1007/BF02982139